ClinicalTrials.gg
RecruitingNCT06198699Updated Apr 13, 2026

Effects of Jing Si Herbal Tea on Quality of Life and Sleep in Dementia and Their Caregivers

An interventional study of Jing Si Herbal Tea in Dementia, Caregiver Burden and Quality of Life, sponsored by National Cheng Kung University. Recruiting at 1 site in Taiwan. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2026-04-13.

Sponsored by National Cheng Kung University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Jan 2025; still recruiting 1 year 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
400
Allocation
Not applicable
Ages
20 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 105 studies in Dementia with a site in Taiwan — 23 open to participants now, 28 under way, 1 of them phase 3. Dementia · Taiwan.

Planned enrollment
8th of 84
400 · median 100
Started
2025
with 14 others
No phase
66 of 105
12 open now
Primary completion
2026-12
later than 12 of 27 live
Registered
71st of 105
by date
Lead sponsor
3 of 105
National Cheng Kung University

Among the 105 studies in Dementia with a site in Taiwan, this one is the 8th largest by planned enrollment of the 84 interventional ones that give a count, is one of 15 that started in 2025, is one of 66 with no phase, reaches primary completion later than 12 of the 27 other live ones, and was the 71st registered.

Dementia

2,377 studies on the registry are indexed under Dementia; 572 are open to participants now.

Browse Dementia studies →

Open to participants now

23 of the 105 studies in Dementia with a site in Taiwan are open now. Recruiting first, the newest first:

17 more — sign in →

All 23 open studies →

A study can be open while its sites in Taiwan have not opened yet or have stopped. Only those recruiting at a site in Taiwan →

Who these studies take

Of the 382 Dementia studies recruiting now, 242 (63%) set no upper age limit and 25 (7%) stop at 75 or younger; 15 take children under 18; 163 take healthy volunteers.

This study: 20 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 105 studies in Dementia with a site in Taiwan, or all of them as a file.
02

Study summary

Jing Si Herbal Tea has been found to be effective in improving health for the conditions of cancers, aging, depression, and sleep. Such evidence has been shown in animal models and clinical research with publications in the international journals. However, empirical evidence regarding the effectiveness of Jing Si Herbal Tea for patients with dementia and their caregivers on their quality of life and psychosocial health remains unclear. Therefore, the present project aims to investigate the feasibility of taking Jing Si Herbal Tea among patients with dementia; then, to investigate if Jing Si Herbal Tea could improve quality of life and psychosocial health for patients with dementia and their caregivers. The project will be three years. The first year will examine the feasibility for the patients with dementia. A total of 100 patients with dementia will be recruited and they will be informed to take the Jing Si Herbal Tea two times per day (one time in the morning and another time in the afternoon). All the participants will be measured for their quality of life and psychosocial health at baseline, three months after baseline, and six months after baseline, to have initial evidence of the improvements in quality of life and psychosocial health without having a control group. The second year will recruit 200 patients with dementia and randomly assign them into a treatment group (taking Jing Si Herbal Tea) and a control group (taking placebo). All the participants will be measured for their quality of life and psychosocial health at baseline, three months after baseline, and six months after baseline, to investigate the strong evidence of Jing Si Herbal Tea on quality of life and psychosocial health. The third year will recruit 200 caregivers of patient with dementia and randomly assign them into a treatment group (taking Jing Si Herbal Tea) and a control group (taking placebo). All the participants will be measured for their quality of life and psychosocial health at baseline, three months after baseline, and six months after baseline, to investigate the strong evidence of Jing Si Herbal Tea on quality of life and psychosocial health.

03

Conditions studied

  • Dementia
  • Caregiver Burden
  • Quality of Life

Keywords

  • dementia
  • caregiver
  • quality of life
  • Jing Si Herbal Tea
  • psychosocial health
  • randomized controlled trial
04

Who can participate

Ages eligible
20 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

For people with dementia:

Inclusion Criteria:

  • diagnosis of dementia
  • 50 years or older
  • with sufficient cognition to complete the questionnaires
  • can communicate using Mandarin or Taiwanese

Exclusion Criteria:

  • with renal function problems
  • not suitable for Jing Si Herbal Tea after evaluation from a psychiatrist/physician
  • with the condition of change the commencement of guardianship (or commencement of assistance)

For caregivers:

Inclusion Criteria:

  • caregivers of people with dementia for more than half years
  • 20 years or older
  • with sufficient cognition to complete the questionnaires
  • can communicate using Mandarin or Taiwanese

Exclusion Criteria:

  • with renal function problems
  • not suitable for Jing Si Herbal Tea after evaluation from a psychiatrist/physician
  • with the condition of change the commencement of guardianship (or commencement of assistance)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
400 participants (estimated)

Study arms

  • Experimental
    Jing Si Herbal Tea Group

    Frequency: Two times of herbal tea (one in the morning; one in the afternoon) per day Duration: Consumption for three months Dosage: One pack (14g) with 600 ml water for each time of herbal tea consumption

    Dietary Supplement: Jing Si Herbal Tea

Interventions

  • Dietary supplementJing Si Herbal Tea

    Consuming Jing Si Herbal Tea for three months; twice per day with each time 14 g of Jing Si Herbal in 600 ml water

06

What researchers measure

Primary outcomes

  1. World Health Organization Quality of Life Assessment for age (WHOQOL-AGE) [for people with dementia]

    quality of life measure; score range 13-65; higher score indicates better quality of life

    Time frame: baseline; 3 months after baseline; 6 months after baseline

  2. Insomnia Severity Index [for both people with dementia and their caregivers]

    sleep problem measure; score range 0-28; higher score indicates more severe insomnia

    Time frame: baseline; 3 months after baseline; 6 months after baseline

  3. World Health Organization Quality of Life Assessment brief version (WHOQOL-BREF) [for caregivers]

    quality of life measure; score range 4-20; higher score indicates better quality of life

    Time frame: baseline; 3 months after baseline; 6 months after baseline

Secondary outcomes

  1. Katz Index of Independence in Activities of Daily Living [for people with dementia]

    activities of daily living function measure; score range 0-6; higher score indicates better activities of daily living

    Time frame: baseline; 3 months after baseline; 6 months after baseline

  2. 5 items of Geriatric Depression Scale [for people with dementia and their caregivers]

    depression measure; score range 0-5; higher score indicates greater depression

    Time frame: baseline; 3 months after baseline; 6 months after baseline

  3. Short Portable Mental Status Questionnaire [for people with dementia]

    cognition measure; score range 0-10; higher score indicates poor cognition

    Time frame: baseline; 3 months after baseline; 6 months after baseline

  4. Clinical Frailty Scale [for people with dementia]

    frailty measure; score range 1-9; higher score indicates more frail

    Time frame: baseline; 3 months after baseline; 6 months after baseline

  5. Integrated care for older people [for people with dementia]

    intrinsic capacity measure; score range 0-13; higher score indicates poorer intrinsic capacity

    Time frame: baseline; 3 months after baseline; 6 months after baseline

  6. Attitude and Thoughts Toward Older People Scale [for people with dementia and their caregivers]

    ageism measure; score range 17-85; higher score indicates higher level of ageism

    Time frame: baseline; 3 months after baseline; 6 months after baseline

  7. Depression, Anxiety, Stress Scale-21 [for people with dementia and their caregivers]

    psychological distress measure; score range 0-63; higher score indicates greater distress

    Time frame: baseline; 3 months after baseline; 6 months after baseline

  8. 12 item of Zarit Burden Interview [for caregivers]

    caregiver burden measure; score range 0-48; higher score indicates greater burden

    Time frame: baseline; 3 months after baseline; 6 months after baseline

Other outcomes

  1. Comorbidity

    Other chronic disease the participants have

    Time frame: baseline

07

Study locations

1 of 1 sites recruiting
  • Tzu-Chi General Hospital
    Hualien City, Taiwan
    Recruiting
    • Hao-Ming Li, MD · Contact
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2025 (actual). Primary completion is estimated for Dec 2026, 23 months after the start.

Of 862 non-industry interventional studies with no phase under Dementia, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 44. This study's planned 23 months is close to that.

Counting every sponsor, half of 908 studies reached it within 25 months; a quarter within 11 and three quarters within 43.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 27, 2023
First posted
Jan 10, 2024
StartActual
Jan 17, 2025
Primary completionEst.
Dec 2026
CompletionEst.
Dec 2026
Last update
Apr 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06198699
Lead sponsor
National Cheng Kung University
Collaborators
Buddhist Tzu Chi General Hospital, Tzu Chi University, E-DA Hospital
Responsible party
Chung-Ying Lin (Professor, National Cheng Kung University) — Principal investigator
First posted
Jan 10, 2024
Start date
Jan 17, 2025
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Apr 13, 2026

Study contacts

Chung-Ying Lin, PhD
Contact
cylin36933@gs.ncku.edu.tw
+886-2353535 ext. 5106
Hao-Ming Li, MD
principal investigator · Buddhist Tzu Chi General Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Jing Si Herbal Tea

Start the discussion